Johnson & Johnson
USUSDJohnson & Johnson (MX:JNJ) — Biotechnology: Pharmaceutical Preparations. Liczba giełd, na których notowane są akcje spółki: 3. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- jnj.com
- Relacje Inwestorskie
- investor.jnj.com/overview/default.aspx
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siedziba
- New Brunswick, United States
- Prezes
- Joaquin Duato
- Pracownicy
- 136 400
- Założona
- 1886
- Notowana od
- 29.05.2003 (MX:JNJ)
- Akcje w Obrocie
- Free Float
- 2.41 mld
- Kapitalizacja Rynkowa
- 655.37 mld USD
- Insiderzy
- 0.05%
- Inwestorzy Instytucjonalni
- 76.73%
- Branża (SIC)
- Pharmaceutical Preparations
- Forma Prawna
- XSNP
- ISIN
- US4781601046
- LEI
- 549300G0CFPGEF6X2043
- P/E
- 40.6
- Stopa Wypłaty
- 60.0%
- FCF
- 22.2 mld USD
- Wypłaty / FCF
- 57%
- Dług
- 49.0 mld USD1.3 l. FCF
- Staż Dywidendowy
- 56+ l.
- Zysk, FCF i wypłacone dywidendy — za 12 miesięcy do 28.06.2026 (najnowszy raport spółki).
- NAV
Opis
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dywidendy
Johnson & Johnson (JNJ) wypłaca dywidendy kwartalnie. Na rok (12 miesięcy do ostatniej ogłoszonej płatności): 5.32 USD na akcję (płatności: 4). To około 2.05% obecnej ceny akcji. Następna data ex-dywidendy to 24.11.2026: 1.34 USD na akcję, wypłata 08.12.2026. Lata nieprzerwanych dywidend: 56.
| Dzień Ex | Wypłata | Kwota | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-11-24 ogłoszona | 2026-12-08 | 1.3400 USD | 0.5/2.1 % | kwartalnie | US:JNJ |
| 2026-08-25 | 2026-09-08 | 1.3400 USD | 0.5/1.9 % | kwartalnie | US:JNJ |
| 2026-05-26 | 2026-06-09 | 1.3400 USD | 0.6/2.2 % | kwartalnie | US:JNJ |
| 2026-02-24 | 2026-03-10 | 1.3000 USD | 0.5/2.1 % | kwartalnie | US:JNJ |
| 2025-11-25 | 2025-12-09 | 1.3000 USD | 0.6/2.5 % | kwartalnie | US:JNJ |
| 2025-08-26 | 2025-09-09 | 1.3000 USD | 0.7/2.8 % | kwartalnie | US:JNJ |
| 2025-05-27 | 2025-06-10 | 1.3000 USD | 0.9/3.3 % | kwartalnie | US:JNJ |
| 2025-02-18 | 2025-03-04 | 1.2400 USD | 0.8/3.2 % | kwartalnie | US:JNJ |
| 2024-11-26 | 2024-12-10 | 1.2400 USD | 0.8/3.2 % | kwartalnie | US:JNJ |
| 2024-08-27 | 2024-09-10 | 1.2400 USD | 0.5/1.9 % | kwartalnie | US:JNJ |
| 2024-05-20 | 2024-06-04 | 1.2400 USD | 0.5/1.9 % | kwartalnie | US:JNJ |
| 2024-02-16 | 2024-03-05 | 1.1900 USD | 0.5/1.8 % | kwartalnie | US:JNJ |
| 2023-11-20 | 2023-12-05 | 1.1900 USD | 0.5/1.8 % | kwartalnie | US:JNJ |
| 2023-08-25 | 2023-09-07 | 1.1900 USD | 0.5/1.8 % | kwartalnie | US:JNJ |
| 2023-05-22 | 2023-06-06 | 1.1900 USD | 0.5/1.8 % | kwartalnie | US:JNJ |
| 2023-02-17 | 2023-03-07 | 1.1300 USD | 0.4/1.7 % | kwartalnie | US:JNJ |
| 2022-11-21 | 2022-12-06 | 1.1300 USD | 0.4/1.7 % | kwartalnie | US:JNJ |
| 2022-08-22 | 2022-09-06 | 1.1300 USD | 0.4/1.7 % | kwartalnie | US:JNJ |
| 2022-05-23 | 2022-06-07 | 1.1300 USD | 0.4/1.3 % | kwartalnie | US:JNJ |
| 2022-02-18 | 2022-03-08 | 1.0600 USD | 0.4/0.8 % | kwartalnie | US:JNJ |
| 2021-11-22 | 2021-12-07 | 1.0600 USD | 0.4/0.4 % | kwartalnie | US:JNJ |
Wiadomości w Tym Tygodniu
Komunikaty prasowe ze strony firmy dla inwestorów, aktualizowane codziennie. Linki prowadzą na stronę firmy. Nagłówki są w oryginalnym języku, jak na stronie internetowej firmy.
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| BlackRock | 8.8% | 212.1 mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.52% | 157.23 mln | 2026-06-30 |
| State Street Corporation | 5.55% | 133.78 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.17% | 76.42 mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.67% | 64.37 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 62.38 mln | 2026-06-30 |
| Geode Capital Management… | 2.45% | 59.09 mln | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.42% | 58.3 mln | 2026-06-30 |
| Morgan Stanley | 1.86% | 44.81 mln | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 32.48 mln | 2026-07-31 |
| NORGES BANK | 1.32% | 31.83 mln | 2026-06-30 |
| State Farm Mutual Automo… | 1.31% | 31.59 mln | 2026-06-30 |
| Fidelity Concord Street… | 1.29% | 31.13 mln | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 29.45 mln | 2026-08-31 |
| Northern Trust Corporati… | 1.19% | 28.79 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 22.91 mln | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.3 mln | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 13.53 mln | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 13.07 mln | 2026-06-30 |
| VANGUARD WHITEHALL FUNDS… | 0.39% | 9.48 mln | 2026-04-30 |
| DUATO JOAQUIN BOIX (Chie… | ≈0.01% | 307 837 | 2026-08-13 |
| TAUBERT JENNIFER L (Offi… | ≈0.01% | 194 451 | 2026-08-17 |
| WENGEL KATHRYN E (Chief… | ≈0% | 114 659 | 2026-06-11 |
| WOLK JOSEPH J (Chief Fin… | ≈0% | 85 008 | 2026-02-17 |
| SCHMID TIMOTHY (Officer) | ≈0% | 26 251 | 2026-09-02 |
| SWANSON JAMES D (Chief T… | ≈0% | 25 698 | 2026-02-17 |
| REED JOHN C (Officer) | ≈0% | 24 911 | 2026-05-01 |
| DECKER ROBERT J (Officer… | ≈0% | 24 462 | 2026-02-27 |
| BROADHURST VANESSA (Offi… | ≈0% | 23 003 | 2026-07-20 |
| MULHOLLAND KRISTEN (Offi… | ≈0% | 19 830 | 2026-02-13 |
| The Vanguard Group | — | — | — |
